Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa

International Journal of Dermatology
Taylor L BraunbergerIltefat H Hamzavi

Abstract

A paucity of knowledge exists regarding the use of ertapenem in hidradenitis suppurativa. Our retrospective chart review and telephone interview aims to investigate the utility of intravenous ertapenem in severe, refractory hidradenitis suppurativa. This retrospective chart review and telephone interview included patients with severe, refractory hidradenitis suppurativa treated with intravenous ertapenem between March 2013 and December 2016. Data were obtained from medical charts. During the telephone interview, patients were asked questions relating to satisfaction, quality of life changes, and disease state changes with ertapenem therapy. A total of 36 patients including 22 females and 14 males with Hurley stage II or III hidradenitis suppurativa were included. Thirty-five patients (97.2%), demonstrated improvements in hidradenitis suppurativa with ertapenem treatment. In total, 28 patients participated in our telephone interview. Twenty patients (71.4%) were very satisfied (n = 12) or satisfied (n = 8). Quality of life improved in 85.7% of patients (n = 24). Following ertapenem therapy, patients reported improvements in quality of life. This treatment appears promising as an adjunct to biologics or as a bridge to surgery in ...Continue Reading

References

Jul 25, 2000·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·R Rompel, J Petres
Apr 12, 2001·The British Journal of Dermatology·J M von der Werth, G B Jemec
May 20, 2004·The Journal of Antimicrobial Chemotherapy·Hedy TepplerRobin Isaacs
Jul 11, 2009·Dermatology : International Journal for Clinical and Investigative Dermatology·G GenerS Bastuji-Garin
Jul 11, 2009·Dermatology : International Journal for Clinical and Investigative Dermatology·Hessel H van der ZeeGregor B E Jemec
Mar 17, 2010·Journal of the American Academy of Dermatology·Łukasz MatusiakJacek C Szepietowski
Jun 24, 2010·The Pediatric Infectious Disease Journal·Susan M Abdel-RahmanJeffrey L Blumer
Nov 27, 2010·Dermatology : International Journal for Clinical and Investigative Dermatology·Olivier Join-LambertAude Nassif
Nov 4, 2011·The New England Journal of Medicine·Vivian G LooAndre Dascal
Mar 8, 2014·Acta Dermato-venereologica·Łukasz MatusiakJacek C Szepietowski
Apr 9, 2014·Antimicrobial Agents and Chemotherapy·Zubair A QureshiYohei Doi
Nov 30, 2014·American Journal of Clinical Dermatology·Afsaneh AlaviR Gary Sibbald
Nov 14, 2015·The Journal of Antimicrobial Chemotherapy·Olivier Join-LambertAude Nassif
Dec 1, 2015·Dermatologic Clinics·Hans Christian Ring, Lennart Emtestam
Aug 27, 2016·The British Journal of Dermatology·H C RingG B Jemec
May 26, 2017·JAMA Dermatology·Hans Christian RingGregor Borut Jemec
Aug 11, 2017·F1000Research·Mallory K SmithIltefat H Hamzavi

❮ Previous
Next ❯

Citations

Aug 24, 2018·Expert Review of Clinical Pharmacology·Claudio MarascaGabriella Fabbrocini
Aug 25, 2020·JAMA Surgery·Judy HamadBradley D Figler
Nov 12, 2020·Journal of Cutaneous Medicine and Surgery·Muskaan SachdevaAfsaneh Alavi
Jun 5, 2021·Experimental Dermatology·Christos C ZouboulisErrol P Prens
Aug 28, 2021·Cells·Emanuele ScalaGabriella Fabbrocini
Sep 24, 2021·Journal of the American Academy of Dermatology·Radhika A ShahStephen K Tyring
May 15, 2020·Dermatology : International Journal for Clinical and Investigative Dermatology·Lauren A V OrensteinIltefat Hamzavi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Dermatology : International Journal for Clinical and Investigative Dermatology
Annika M J D VanlaerhovenHessel H van der Zee
JAAD Case Reports
Adam A ChahineIltefat H Hamzavi
Journal of the American Academy of Dermatology
Rachel G CasseresDavid Rosmarin
© 2022 Meta ULC. All rights reserved